Anatara Lifesciences is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Our lead product Detach™ is a natural product that will help address global concerns around the overuse of antibiotics in animals and their feed that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies.
Latest news All news
BRISBANE, November 19, 2014: Anatara Lifesciences, a company developing non-antibiotic treatments for gastrointestinal diseases in animals and humans, has welcomed Antibiotic Awareness Week in Australia to increase awareness around the threat to human health of antibiotic resistance.Read more »
Anatara has featured on one of Australia’s leading business television programs, Financial Review Sunday.
The program was about companies listing on the Australian Securities Exchange (ASX) in 2014 and included an interview with Anatara’s chief scientific officer and co-founder Dr Tracey Mynott.
Dr Mynott explained how stringent regulatory requirements necessary to list on the ASX validates the company and provides confidence to potential overseas partners.
To watch the video click here.